Fetal Growth Restriction: Clinical Trials

1 trial for Fetal Growth Restriction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Terminated 1

Follow Fetal Growth Restriction: new trials by email Literature Review of Fetal Growth Restriction trials Research Report on Fetal Growth Restriction

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Dutch STRIDER (Sildenafil TheRapy In Dismal Prognosis Early-onset Fetal Growth Restriction)
Sildenafil, Placebo - Fetal Growth Restriction
Phase 2 / Phase 3TerminatedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2162015-01-012026-11-04

Narrower conditions

Fetal Growth Retardation (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Fetal Diseases (1)  ·  Growth Disorders (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pregnancy Complications (1)  ·  Urogenital Diseases (1)

Interventions

Sildenafil Citrate (1)

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)

Countries

Netherlands (1)

Top investigators

A. van Wassenaer, MD PhD (1)  ·  B.W. Mol, Prof (1)  ·  C de Groot, Prof (1)  ·  J.W. Ganzevoort, MD PhD (1)  ·  K Bloemenkamp, MD PhD (1)  ·  M. Porath, MD PhD (1)  ·  M.W. de Laat, MD PhD (1)  ·  P von Dadelszen, Prof (1)

Results publications

PMID 29282009, PMID 30635020, PMID 32585017